Analysis of the serotonin transporter promoter rs25531 polymorphism in premenstrual dysphoric disorder

Am J Obstet Gynecol. 2010 Aug;203(2):181.e1-5. doi: 10.1016/j.ajog.2010.02.043. Epub 2010 May 11.

Abstract

Objective: The objective of this study was to investigate whether the functional rs25531 promoter polymorphism in the serotonin transporter gene is associated with premenstrual dysphoric disorder.

Study design: The study sample comprised 53 women with clinically diagnosed premenstrual dysphoric disorder (age range, 27-46 years; mean, 37.7 years) and 52 healthy control subjects (age range, 22-48 years; mean, 36.2 years). The rs25531 polymorphism was genotyped in both groups. Because of its close proximity to rs25531, the 5-HTTLPR promoter polymorphism was also genotyped. Genotype and allele frequencies for rs25531 and for the composite 5-HTTLPR/rs25531 marker were analyzed by chi(2) test.

Results: There was no significant association between any genotype and clinical category and no significant allele distribution profiles for rs25531 or 5-HTTLPR/rs25531 in either the premenstrual dysphoric disorder or the control groups.

Conclusion: These findings do not support a major role for rs25531, either in isolation or combined with 5-HTTLPR, in contributing to susceptibility to premenstrual dysphoria.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Case-Control Studies
  • Female
  • Genetic Predisposition to Disease*
  • Humans
  • Middle Aged
  • Polymerase Chain Reaction
  • Polymorphism, Genetic*
  • Polymorphism, Single Nucleotide
  • Premenstrual Syndrome / genetics*
  • Premenstrual Syndrome / psychology*
  • Probability
  • Promoter Regions, Genetic
  • Reference Values
  • Risk Assessment
  • Serotonin Plasma Membrane Transport Proteins / genetics*
  • Severity of Illness Index

Substances

  • Serotonin Plasma Membrane Transport Proteins